PALO ALTO, Calif.--(BUSINESS WIRE)--StemCells, Inc. (NASDAQ:STEM) announced today that the U.S. Patent and Trademark Office (PTO) has upheld two of the Company’s neural stem cell patents, with only minor amendments, thereby rejecting the arguments raised by Neuralstem, Inc. in its reexamination petitions of last year.
